Africa News of Friday, 10 September 2021Source: aljazeera.comSouth Africa has started vaccinating children and adolescents as part of the global phase three clinical trials of China’s Sinovac Biotech COVID-19 vaccine for people aged between six months and 17 years old. The global study will enroll 2,000 participants in South Africa and 12,000 others will be taking part in Kenya, the Philippines, Chile, and Malaysia. Glenda Gray, president of the South African Medical Research Council, said during Friday’s event that “delaying the inclusion of children in the COVID-19 vaccine trials delays our ability to contain COVID-19”. South Africa accounts for more than 35 percent of COVID-19 infections in Africa, with 2.8 million confirmed cases, including 84,327 deaths. More than seven million people have been fully vaccinated with either the single-shot Johnson & Johnson vaccine or the two-dose Pfizer-BioNTech vaccine.

Source: GhanaWeb September 10, 2021 16:07 UTC